Logo

Alphabet's Verily Establishes CLIA-Certified Lab Focusing on COVID-19 Testing

Share this
Alphabet's Verily Establishes CLIA-Certified Lab Focusing on COVID-19 Testing

Alphabet's Verily Establishes CLIA-Certified Lab Focusing on COVID-19 Testing

Shots:

  • Verily has expedite the COVID-19 testing with a new lab-based at South San Francisco. The lab will use the technology from Thermo Fisher Scientific’s‎ TaqPath test kit that has received the US FDA’s EUA to test COVID-19
  • Verily has submitted a EUA for an adaptation of the TaqPath test to use in testing pooled patient specimens. Pooling is expected to enable our clinical lab to increase our testing capacity even further while maintaining a high level of overall test performance.
  • Additionally- the company has verified the Roche Elecsys anti-SARS-CoV-2 Ab test and plans to implement additional tests in our lab

­ Ref: Verily | Image: The Business Journal

Click here to­ read the full press release 

Tuba

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions